Fulgent Genetics (FLGT) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$6.8 million.
- Fulgent Genetics' Income towards Parent Company rose 5366.14% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.2 million, marking a year-over-year increase of 7248.56%. This contributed to the annual value of -$43.8 million for FY2024, which is 7324.35% up from last year.
- Latest data reveals that Fulgent Genetics reported Income towards Parent Company of -$6.8 million as of Q3 2025, which was up 5366.14% from -$19.2 million recorded in Q2 2025.
- Over the past 5 years, Fulgent Genetics' Income towards Parent Company peaked at $200.7 million during Q1 2021, and registered a low of -$122.9 million during Q4 2023.
- For the 5-year period, Fulgent Genetics' Income towards Parent Company averaged around $21.0 million, with its median value being -$9.1 million (2024).
- In the last 5 years, Fulgent Genetics' Income towards Parent Company skyrocketed by 1185694.2% in 2021 and then tumbled by 110268.06% in 2023.
- Quarter analysis of 5 years shows Fulgent Genetics' Income towards Parent Company stood at $103.7 million in 2021, then tumbled by 123.22% to -$24.1 million in 2022, then crashed by 410.33% to -$122.9 million in 2023, then soared by 94.95% to -$6.2 million in 2024, then fell by 9.66% to -$6.8 million in 2025.
- Its Income towards Parent Company stands at -$6.8 million for Q3 2025, versus -$19.2 million for Q2 2025 and -$11.9 million for Q1 2025.